Paradoxical Response to Enzyme Replacement Therapy of Fabry Disease Cardiomyopathy

被引：2
|
作者：
Frustaci, Andrea [1 ]
Russo, Matteo A. [2 ]
Chimenti, Cristina [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Cardiovasc Resp Nefrol & Geriatr Sci, Viale Policlin 155, I-00161 Rome, Italy
[2] San Raffaele Univ, Meb Consortium, Rome, Italy
来源：
CIRCULATION-CARDIOVASCULAR IMAGING | 2016年 / 9卷 / 08期
关键词：
atenolol; biopsy; cell size; dyspnea; Fabry disease;
D O I：
10.1161/CIRCIMAGING.116.005078
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Utility of enzyme replacement therapy in Fabry disease
    Manuel Politei, Juan
    Dubroysky, Alberto
    MEDICINA CLINICA, 2010, 134 (09): : 402 - 405
  • [22] Fabry disease: Efficacy of enzyme replacement therapy
    Zampetti, A.
    Amerio, P. L.
    De Simone, C.
    Antuzzi, D.
    Ricci, R.
    Feliciani, C.
    ACTA PAEDIATRICA, 2007, 96 : 102 - 102
  • [23] Evaluating Enzyme Replacement Therapy in Fabry Disease
    Koskenvuo, Juha W.
    Kantola, Ilkka M.
    ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (06) : 573 - 574
  • [24] Fabry disease in children and response to enzyme replacement therapy: results from the fabry outcome survey
    Ramaswami, U.
    Parini, R.
    Pintos-Morell, G.
    Hartung, R.
    Kampmann, C.
    Beck, M.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 : 122 - 122
  • [25] Fabry disease in children and response to enzyme replacement therapy: results from the Fabry Outcome Survey
    Ramaswami, U.
    Parini, R.
    Pintos-Morell, G.
    Kalkum, G.
    Kampmann, C.
    Beck, M.
    CLINICAL GENETICS, 2012, 81 (05) : 485 - 490
  • [26] Immune response to enzyme replacement therapy in Fabry disease: Impact on clinical outcome?
    Hollak, C. E. M.
    Linthorst, G. E.
    MOLECULAR GENETICS AND METABOLISM, 2009, 96 (01) : 1 - 3
  • [27] Response of rapidly progressive Fabry disease nephropathy in a female to enzyme replacement therapy
    West, M
    Geldenhuys, L
    Lemoine, K
    ACTA PAEDIATRICA, 2006, 95 : 134 - 134
  • [28] PR interval and the response to enzyme-replacement therapy for Fabry's disease
    Waldek, S
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (12): : 1186 - 1187
  • [29] Impact of enzyme replacement therapy and migalastat on left atrial strain and cardiomyopathy in patients with Fabry disease
    Pogoda, Christian
    Brand, Stefan-Martin
    Duning, Thomas
    Schmidt-Pogoda, Antje
    Sindermann, Juergen
    Lenders, Malte
    Brand, Eva
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [30] Evaluation of Proinflammatory Prognostic Biomarkers for Fabry Cardiomyopathy With Enzyme Replacement Therapy
    Chen, Kuan-Hsuan
    Chien, Yueh
    Wang, Kang-Ling
    Leu, Hsin-Bang
    Hsiao, Chen-Yuan
    Lai, Ying-Hsiu
    Wang, Chien-Ying
    Chang, Yuh-Lih
    Lin, Shing-Jong
    Niu, Dau-Ming
    Chiou, Shih-Hwa
    Yu, Wen-Chung
    CANADIAN JOURNAL OF CARDIOLOGY, 2016, 32 (10) : 1221.e1 - 1221.e9
12345